DOI: 10.1097/01.COT.0000289950.67074.29
,
Issn Print: 0276-2234
Publication Date: 2002/08/01
Facebook
Twitter
LinkedIn
Email
 |
Checking for direct PDF access through Ovid | |
Excerpt
Bruce D. Cheson, MD, has been appointed Head of Hematology and Director of Hematology Research at Lombardi Cancer Center at Georgetown University Medical Center. He had been Head of the Medicine Section in the NCI's Clinical Investigations Branch and Senior Staff Physician in the Institute's Lymphoma Clinic.
The Oncology Nursing Society presented its Honor Award to four US Senators: Sam Brownback (R-KS); Dianne Feinstein, (D-CA); Bill Frist (R-TN); and Edward M. Kennedy (D-MA). Three members of the House were also honored: Reps. Ken Bentsen (D-TX); Sue Myrick (R-NC); and Deborah Pryce (R-OH). The awards, which were presented as part of the first ONS Congressional Hill Day, recognized the recipients' commitment to fighting cancer and their efforts to bolster and expand the nursing workforce.
Robert J. Coffey, Jr., MD, will direct a new NIH Specialized Program of Research Excellence (SPORE) at Vanderbilt-Ingram Cancer Center, where he is Professor of Cancer Research and Professor of Medicine and Cell and Developmental Biology at the Nashville-based Center. The five-year $13 million grant will fund an interdisciplinary program focused on colorectal cancer, with $2.75 million a year going to support five research projects focusing on translational research, and six cores.
José Baselga, MD, will serve as administrator and principal investigator of a five-year $500,000 Unrestricted Cancer Research Grant from Bristol-Myers Squibb to Vall d'Hebron University Hospital in Barcelona, Spain. The funds will support research on epidermal growth factor receptors (EGFRs). Dr. Baselga, Director of the Instituto Oncologico Teknon, an affiliate of Memorial Sloan-Kettering Cancer Center, pioneered the clinical application of trastuzumab (Herceptin), the first monoclonal antibody to target EGFRs.
Fox Chase Cancer Center has announced two new appointments: Oleh Haluszka, MD, as Director of Gastrointestinal Endoscopy, and Minhhuyen Thi Nguyen, MD, as Director of Clinical Gastroenterology in the Department of Medical Oncology.
Andrew L. Pecora, MD, an expert in blood and bone marrow stem cell transplantation, has been named Chairman and Director of the Cancer Center at Hackensack (NJ) University Medical Center.
Two faculty members at H. Lee Moffitt Cancer Center have received grants from the Lymphoma Research Foundation (LRF). Eduardo Sotomayor, MD, Assistant Professor of Oncology and Medicine, was awarded $125,000 to support his work on a lymphoma vaccine; and Hirohito Yamaguchi, DVM, PhD, a postdoctoral fellow, received $45,000 to fund his research into the action of the Bcl-2 gene that is activated by most non-Hodgkin's lymphomas and appears to facilitate tumor resistance to chemotherapy and radiation.
In other news from the Moffitt Center, Cathy Meade, PhD, RN, Director of Education and Associate Professor in the Department of Interdisciplinary Oncology, has been selected for a fellowship from the American Academy of Nursing.
Kunle Odunsi, MD, PhD, an attending physician in the Division of Gynecologic Oncology at Roswell Park Cancer Institute, has been awarded a three-year, $700,000 Cancer Vaccine Collaborative grant from the Cancer Research Institute. The funds will be used to support a study titled “Antigen Specific Vaccine Therapy for Ovarian Cancer Utilizing NY-ESO-1 [an ovarian cancer antigen] as Target.”
Kathleen Mooney, PhD, RN, Professor at the College of Nursing at the University of Utah, has been appointed to a three-year term on the Institute of Medicine's National Cancer Policy Board.
